The LLP risk model (Cassidy et al 2007) has been validated in external Case-Control and Cohort studies (Raji et al 2010). There are now three feasibility studies underway to assess ...

CURELUNG aims to help define the genetic and epigenetic profile of lung cancer.

LCAOS aims to enable the earliest possible detection of lung cancer using volatile biomarkers present in exhaled breath.

Researchers at the University of Liverpool have launched a trial to investigate if a lung cancer screening programme could be implemented effectively at hospitals and cancer centres across the UK...